The global endoscope reprocessing device market is likely to grow at a CAGR of nearly 8% during the forecast period 2017-2027, according to a new research report added to the repository of Market Research Reports Search Engine (MRRSE). The global market is currently valued at nearly US$ 950 Mn, and it is likely to surpass US$ 2 Bn in revenues by the end of 2027-end. According to the report titled “Endoscope Reprocessing Device Market: Hospitals to Remain Most Attractive Segment by End User During the Forecast Period: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2027)”, the global market will continue to be influenced by growing geriatric population, increasing spending on healthcare, and development of advanced techniques. However, there are a number of impediments that can stymie market growth during the assessment period.
Request a Free PDF Sample @ https://www.mrrse.com/sample/4011
According to the report, some of the key factors that are restraining the adoption of endoscope reprocessing devices include concerns about adverse health impact, inadequate reimbursement policies, and increase in excise duty imposed on medical device manufacturers. Development of alternative and safe techniques can also create challenges for the growth of the market.
On the basis of end-users, the report offers detailed analysis and impact on hospitals, specialty clinics, and ambulatory surgical centers. The demand for endoscope reprocessing devices from these end-use industries in key markets of North America, Latin America, Eastern Europe, Western Europe, APEJ, Japan, and MEA has been thoroughly analyzed in the report. According to the study, North America and APEJ are among the leading markets for endoscope reprocessing devices globally. North America has traditionally remained one of the leading markets for endoscope reprocessing devices, whereas Asia Pacific excluding Japan (APEJ) is quickly becoming an important market for medical device and pharmaceutical companies. Decades of economic growth in key countries, most importantly China and India, has led to the emergence of a strong middle class, which is demanding quality healthcare services. The changing demographic has given a boost to medical device and pharmaceutical sales in the region, which in turn has provided an impetus to the endoscope reprocessing device market as well.
Read the full report with TOC @ https://www.mrrse.com/endoscope-reprocessing-device-market
The report also offers key insights and analysis on the key players operating in the endoscope reprocessing devices market. Some of the leading companies profiled in the report include Shinva Medical Instrument co., Ltd., Olympus Corp., Medivators Inc., SciCan Ltd (Sanavis Group), Antonio Matachana SA STERIS Plc., Choyang Medical Industry Ltd., Custom Ultrasonics, Inc., Getinge Group, Hoya Group, Laboratoires Anios, Steelco S.P.A, DGM Pharma-Apparate Handel Ag, MMM Medical Equipment UK LTD, ARC Healthcare Solutions Inc., Medonica Co. Ltd., Belimed AG (Metall Zug), and Advanced Sterilization Products Services Inc.
Leave a Query @ https://www.mrrse.com/enquiry/4011